BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Research and Markets: Nanotechnology Stocks Directory: Directory of the Leading Publicly Traded Nanotech Stocks such as TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX and AIM
Posted on June 24, 2010 at 13:00 PM EDT

Research and Markets (http://www.researchandmarkets.com/research/6005a7/nanotechnology_sto) has announced the addition of the "Nanotechnology Stocks Directory" directory to their offering.

Nanotechnology Stocks Directory-Investorideas.com global stock directory of publicly traded nanotech stocks on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM, Hong Kong and China and other leading Stock Exchanges. Directory includes nanotech- biotech companies, nanotech water and renewable energy companies and more. Directory features company description, stock symbol and hyperlink to recent quote and info, link to website and more

Sample:

A123 Systems, Inc. (NasdaqGM:AONE) develops and manufactures advanced lithium-ion batteries and battery systems for the transportation, electric grid services and consumer markets. Founded in 2001 and headquartered in Massachusetts, A123 Systems' proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology.

ABB Ltd. (NYSE:ABB) is a leader in power and automation technologies that enable utility and industry customers to improve performance while lowering environmental impact. The ABB group of companies operates in some 100 countries and employs approximately 120,000 people. The ABB Corporate Research facilities in both Sweden and Poland are currently working on nanotechnology and advanced materials technologies.

Abraxis Bioscience ( NasdaqGS:ABII) is a fully integrated biotechnology company dedicated to delivering progressive therapeutics and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. The Abraxis portfolio includes the world's first and only protein-based nanoparticle chemotherapeutic compound (ABRAXANE) which is based on its proprietary tumor targeting system known as the nab Technology platform.

Accelrys ( NasdaqGM:ACCL) develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Our customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. The Accelrys Nanotechnology Consortium has delivered a range of cutting-edge software tools to meet the challenges of rational nanodesign. Following a very successful Phase I, supported by over 30 members worldwide, Phase II is now under way. Phase II focuses on developing tools and protocols that bridge the gap between atomistic simulations and engineering applications in the area of reaction kinetics. Key areas of development include QM/MM hybrid methods, Tight Binding DFT, reaction rate constant calculations by means of Transition State Theory, and Kinetic Monte Carlo simulation. The tools developed support research in a range of areas but specificially in surface and iinterface phenomena such as adhesion, coatings and heterogeneous catalysis.

Acusphere Inc. (OTCPK:ACUS) is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microsphere technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. Our lead product candidate, Imagify (Perflubutane Polymer Microspheres) for Injectable Suspension, is a cardiovascular drug for the detection of coronary artery disease, the leading cause of death in the United States. Imagify and the Company's other product candidates were created using proprietary technology that enables Acusphere to control the porosity and size of nanoparticles and microspheres in a versatile manner that allows them to be customized to address the delivery needs of a variety of drugs.

Advance Nanotech, Inc. ( OTCBB:AVNA) owns a minority position in Owlstone Nanotech, Inc. ("Owlstone"). Owlstone is a pioneer in the commercialization of chemical detection products. The Owlstone detector is a revolutionary dime-sized sensor that can be programmed to detect a wide range of chemical agents that may be present in extremely small quantities. Using leading-edge micro- and nano-fabrication techniques, Owlstone has created a complete chemical detection sensor that is significantly smaller and can be produced more cost effectively than products using existing technology. There are numerous applications -- across industries from security and defense to industrial process, air quality control and healthcare -- that depend on the rapid, accurate detection and measurement of chemical compounds. Owlstone works with market leaders within these industries to integrate the detector into next generation chemical sensing products and solutions. Owlstone's technology offers a unique combination of benefits, including small size, low manufacturing costs, minimal power consumption, reduced false-positives, and a customizable platform.

Agilent Technologies Inc. ( NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences, and chemical analysis. The company's 17,000 employees serve customers in more than 110 countries. Agilent had net revenues of $4.5 billion in fiscal 2009. Nanomechanical Instruments: Agilent offers high-precision, modular nanomeasurement solutions for research, industry and education. Exceptional worldwide support is provided by experienced application scientists and technical service personnel. Our leading-edge R&D laboratories ensure the continued, timely introduction and optimization of innovative, easy-to-use nanomeasurement technologies.

Aixtron AG (NasdaqGS:AIXG; Frankfurt::AIXA.F) is a leading provider of deposition equipment to the semiconductor industry. The Company's technology solutions are used by a diverse range of customers worldwide to build advanced components for electronic and opto-electronic applications based on compound, silicon, or organic semiconductor materials and more recently carbon nanostructures. Such components are used in display technology, signal and lighting technology, fiber communication networks, wireless and cell telephony applications, optical and electronic data storage, computer technology as well as a wide range of other high-tech applications.

Altair Nanotechnologies (NasdaqCM:ALTI) is a leader in advanced energy storage systems for clean, efficient power and energy management, Altairnano's suite of advanced lithium-ion energy storage systems is helping solve today's toughest power and energy challenges. Altairnano is the first company to replace traditional graphite materials used in conventional lithium-ion batteries with a proprietary, nano-structured lithium titanate a process that delivers distinctive performance attributes, including power, fast charge/discharge rates, high round-trip efficiencies, long cycle life, safety, and ability to operate under extreme temperatures.

For more information visit http://www.researchandmarkets.com/research/6005a7/nanotechnology_sto

Contacts:

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here